A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy

NCT00999167 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Cirrhosis
Hepatic Encephalopathy

Interventions

DRUG: HPN-100
DRUG: Placebo

Sponsor

Amgen